Skip to main content
NCBI home page
Clinical and Experimental Immunology logoLink to Clinical and Experimental Immunology
. 1984 Jan;55(1):239–244.

Decrease of peripheral large granular lymphocytes in Graves' disease.

Y Iwatani, N Amino, O Kabutomori, H Mori, H Tamaki, S Motoi, Y Izumiguchi, K Miyai
PMCID: PMC1535766  PMID: 6546360

Abstract

Peripheral large granular lymphocytes (LGL) were enumerated in normal subjects and patients with autoimmune thyroid diseases. In normal subjects, the percentage of LGL was significantly lower in women (mean +/- s.d., 17.0 +/- 3.6%; n = 35; P less than 0.05) than in men (19.5 +/- 5.3%; n = 20). In untreated patients with thyrotoxic Graves' disease (GD), both the percentage (11.5 +/- 2.7%; n = 12; P less than 0.001) and the absolute count (244 +/- 102/mm3; P less than 0.01) of LGL were significantly lower than those in normal women (17.0 +/- 3.6% and 334 +/- 122/mm3; n = 35). No significant differences from normal controls were observed in the percentages or absolute counts of LGL in patients with euthyroid GD under treatment or in euthyroid or hypothyroid patients with Hashimoto's disease (HD). The percentage of LGL was inversely correlated with the serum levels of T4 and T3 and the free T4 index, but not with the titre of anti-thyroid antibodies, the size of goitre or the degree of proptosis in the group of untreated patients with GD and HD. The decreased levels of LGL in thyrotoxic patients with GD may be related to the self-perpetuation of thyrotoxicosis in patients with this disease.

Full text

PDF
239

Images in this article

240Fig. 1
on p.240

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Abo T., Balch C. M. A differentiation antigen of human NK and K cells identified by a monoclonal antibody (HNK-1). J Immunol. 1981 Sep;127(3):1024–1029. [PubMed] [Google Scholar]
  2. Abo T., Cooper M. D., Balch C. M. Postnatal expansion of the natural killer and keller cell population in humans identified by the monoclonal HNK-1 antibody. J Exp Med. 1982 Jan 1;155(1):321–326. doi: 10.1084/jem.155.1.321. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Abo T., Miller C. A., Gartland G. L., Balch C. M. Differentiation stages of human natural killer cells in lymphoid tissues from fetal to adult life. J Exp Med. 1983 Jan 1;157(1):273–284. doi: 10.1084/jem.157.1.273. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Adams D. D. Thyroid-stimulating autoantibodies. Vitam Horm. 1980;38:119–203. doi: 10.1016/s0083-6729(08)60485-9. [DOI] [PubMed] [Google Scholar]
  5. Amino N., Hagen S. R., Yamada N., Refetoff S. Measurement of circulating thyroid microsomal antibodies by the tanned red cell haemagglutination technique: its usefulness in the diagnosis of autoimmune thyroid diseases. Clin Endocrinol (Oxf) 1976 Mar;5(2):115–125. doi: 10.1111/j.1365-2265.1976.tb02822.x. [DOI] [PubMed] [Google Scholar]
  6. Bolhuis R. L., Schuit H. R., Nooyen A. M., Ronteltap C. P. Characterization of natural killer (NK) cells and killer (K) cells in human blood: discrimination between NK and K cell activities. Eur J Immunol. 1978 Oct;8(10):731–740. doi: 10.1002/eji.1830081012. [DOI] [PubMed] [Google Scholar]
  7. Bonnyns M., Cano P., Osterland C. K., McKenzie J. M. Immune reactions in patients with Graves' disease. Am J Med. 1978 Dec;65(6):971–977. doi: 10.1016/0002-9343(78)90749-0. [DOI] [PubMed] [Google Scholar]
  8. Calder E. A., Penhale W. J., Barnes E. W., Irvine W. J. Evidence for circulating immune complexes in thyroid disease. Br Med J. 1974 Apr 6;2(5909):30–31. doi: 10.1136/bmj.2.5909.30. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Chopra I. J. Gonadal steroids and gonadotropins in hyperthyroidism. Med Clin North Am. 1975 Sep;59(5):1109–1121. doi: 10.1016/s0025-7125(16)31961-7. [DOI] [PubMed] [Google Scholar]
  10. Finkelstein J. W., Boyar R. M., Hellman L. Growth hormone secretion in hyperthyroidism. J Clin Endocrinol Metab. 1974 Apr;38(4):634–637. doi: 10.1210/jcem-38-4-634. [DOI] [PubMed] [Google Scholar]
  11. Gallagher T. F., Hellman L., Finkelstein J., Yoshida K., Weitzman E. D., Roffwarg H. D., Fukushima D. K. Hyperthyroidism and cortisol secretion in man. J Clin Endocrinol Metab. 1972 Jun;34(6):919–927. doi: 10.1210/jcem-34-6-919. [DOI] [PubMed] [Google Scholar]
  12. Gidlund M., Orn A., Wigzell H., Senik A., Gresser I. Enhanced NK cell activity in mice injected with interferon and interferon inducers. Nature. 1978 Jun 29;273(5665):759–761. doi: 10.1038/273759a0. [DOI] [PubMed] [Google Scholar]
  13. Hansson M., Kärre K., Kiessling R., Roder J., Andersson B., Häyry P. Natural NK-cell targets in the mouse thymus: characteristics of the sensitive cell population. J Immunol. 1979 Aug;123(2):765–771. [PubMed] [Google Scholar]
  14. Herberman R. B., Holden H. T. Natural cell-mediated immunity. Adv Cancer Res. 1978;27:305–377. doi: 10.1016/s0065-230x(08)60936-7. [DOI] [PubMed] [Google Scholar]
  15. Herberman R. B., Ortaldo J. R. Natural killer cells: their roles in defenses against disease. Science. 1981 Oct 2;214(4516):24–30. doi: 10.1126/science.7025208. [DOI] [PubMed] [Google Scholar]
  16. Hochman P. S., Cudkowicz G. Suppression of natural cytotoxicity by spleen cells of hydrocortisone-treated mice. J Immunol. 1979 Sep;123(3):968–976. [PubMed] [Google Scholar]
  17. Hsu C. C., Chen Y., Patterson R. Peripheral blood B-lymphocyte abnormalities associated with hyperthyroidism of Graves' disease. Clin Exp Immunol. 1976 Dec;26(3):431–440. [PMC free article] [PubMed] [Google Scholar]
  18. Iwatani Y., Amino N., Mori H., Asari S., Izumiguchi Y., Kumahara Y., Miyai K. T lymphocyte subsets in autoimmune thyroid diseases and subacute thyroiditis detected with monoclonal antibodies. J Clin Endocrinol Metab. 1983 Feb;56(2):251–254. doi: 10.1210/jcem-56-2-251. [DOI] [PubMed] [Google Scholar]
  19. Mariotti S., DeGroot L. J., Scarborough D., Medof M. E. Study of circulating immune complexes in thyroid diseases: comparison of Raji cell radioimmunoassay and specific thyroglobulin-antithyroglobulin radioassay. J Clin Endocrinol Metab. 1979 Nov;49(5):679–686. doi: 10.1210/jcem-49-5-679. [DOI] [PubMed] [Google Scholar]
  20. Mori H., Amino N., Iwatani Y., Asari S., Izumiguchi Y., Kumahara Y., Miyai K. Decrease of immunoglobulin G-Fc receptor-bearing T lymphocytes in Graves' disease. J Clin Endocrinol Metab. 1982 Sep;55(3):399–402. doi: 10.1210/jcem-55-3-399. [DOI] [PubMed] [Google Scholar]
  21. Mori H., Amino N., Iwatani Y., Kabutomori O., Asari S., Motoi S., Miyai K., Kumahara Y. Increase of peripheral B lymphocytes in Graves' disease. Clin Exp Immunol. 1980 Oct;42(1):33–40. [PMC free article] [PubMed] [Google Scholar]
  22. Nabel G., Allard W. J., Cantor H. A cloned cell line mediating natural killer cell function inhibits immunoglobulin secretion. J Exp Med. 1982 Aug 1;156(2):658–663. doi: 10.1084/jem.156.2.658. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Rook A. H., Tsokos G. C., Quinnan G. V., Jr, Balow J. E., Ramsey K. M., Stocks N., Phelan M. A., Djeu J. Y. Cytotoxic antibodies to natural killer cells in systemic lupus erythematosus. Clin Immunol Immunopathol. 1982 Aug;24(2):179–185. doi: 10.1016/0090-1229(82)90229-x. [DOI] [PubMed] [Google Scholar]
  24. Saxena Q. B., Saxena R. K., Adler W. H. Regulation of natural killer activity in vivo. III. Effect of hypophysectomy and growth hormone treatment on the natural killer activity of the mouse spleen cell population. Int Arch Allergy Appl Immunol. 1982;67(2):169–174. [PubMed] [Google Scholar]
  25. Saxena R. K., Saxena Q. B., Adler W. H. Regulation of natural killer activity in vivo: Part I--loss of natural killer activity during starvation. Indian J Exp Biol. 1980 Dec;18(12):1383–1386. [PubMed] [Google Scholar]
  26. Seaman W. E., Merigan T. C., Talal N. Natural killing in estrogen-treated mice responds poorly to poly I.C despite normal stimulation of circulating interferon. J Immunol. 1979 Dec;123(6):2903–2905. [PubMed] [Google Scholar]
  27. Sharma S. D., Tsai V., Proffitt M. R. Enhancement of mouse natural killer cell activity by thyroxine. Cell Immunol. 1982 Oct;73(1):83–97. doi: 10.1016/0008-8749(82)90437-3. [DOI] [PubMed] [Google Scholar]
  28. Timonen T., Ortaldo J. R., Herberman R. B. Characteristics of human large granular lymphocytes and relationship to natural killer and K cells. J Exp Med. 1981 Mar 1;153(3):569–582. doi: 10.1084/jem.153.3.569. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Timonen T., Saksela E., Ranki A., Häyry P. Fractionation, morphological and functional characterization of effector cells responsible for human natural killer activity against cell-line targets. Cell Immunol. 1979 Nov;48(1):133–148. doi: 10.1016/0008-8749(79)90106-0. [DOI] [PubMed] [Google Scholar]
  30. Wall J. R., Baur R., Schleusener H., Bandy-Dafoe P. Peripheral blood and intrathyroidal mononuclear cell populations in patients with autoimmune thyroid disorders enumerated using monoclonal antibodies. J Clin Endocrinol Metab. 1983 Jan;56(1):164–169. doi: 10.1210/jcem-56-1-164. [DOI] [PubMed] [Google Scholar]

Articles from Clinical and Experimental Immunology are provided here courtesy of British Society for Immunology

RESOURCES